YuYu Pharma (South Korea)

Recent papers from YuYu Pharma (South Korea)

1. Formulation and Bioequivalence Evaluation of a Miniaturized Fexofenadine Hydrochloride TabletPharmaceutics · 2025
2. Effect of a herbal extract powder (YY-312) from Imperata cylindrica Beauvois, Citrus unshiu Markovich, and Evodia officinalis Dode on body fat mass in overweight adults: a 12-week, randomized, double-blind, placebo-controlled, parallel-group clinical trialBMC Complementary and Alternative Medicine · 2017
3. YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2Journal of Neuroinflammation · 2017
4. Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic systemPhytomedicine · 2016
5. Effects of Gut Microflora on Pharmacokinetics of Hesperidin: A Study on Non-Antibiotic and Pseudo-Germ-Free RatsJournal of Toxicology and Environmental Health · 2010
6. Determination of Urinary Trimethylamine and Trimethylamine N-oxide by Liquid Chromatography-Tandem Mass Spectrometry Using Mixed-Mode Stationary PhasesBulletin of the Korean Chemical Society · 2010
7. Inhibitory Effects of Deoxypodophyllotoxin fromAnthriscus sylvestrison Human CYP2C9 and CYP3A4Planta Medica · 2009